The thrombotic profile of treatment-naive HIV-positive black South Africans with acute coronary syndromes

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 3, 2011, Pages 264-272

  Becker, A C ^a,b   Jacobson, B ^c   Singh, S ^d   Sliwa, K ^a,b   Stewart, S ^a,b,e   Libhaber, E ^a,b   Essop, M R ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d LANCET LABORATORIES   (South Africa)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

acute coronary syndromes; blood coagulation factors; clinical thrombophilia; hypercoagulability; thrombophilia; thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN C; PROTEINASE INHIBITOR; PROTHROMBIN ANTIBODY; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKING; SOUTH AFRICA; THROMBOPHILIA; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE CORONARY SYNDROME; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; ANTIBODIES, ANTICARDIOLIPIN; FACTOR VIII; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN C; RISK FACTORS; SOUTH AFRICA; THROMBOPHILIA;

EID: 79955838241     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029609358883     Document Type: Article

References (44)

1. Muhammad W, Greenberg B. HIV and thrombosis: a review. AIDS Patient Care STDS. 2001;15(1):1-24.
2. Yu-Min P. Thrombosis and hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost. 2004;10(3):277-280.
3. Micieli E, Dentali F, Giola M, Grossi P, Venco A, Ageno W. Venous and arterial thrombosis in patients with HIV infection. Blood Coagul Fibrinolysis. 2007;18(3):259-263. (Pubitemid 46597399)
4. Hazenberg MD, Stuart JW, Otto SA, et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood. 2000;95(1):249-255. (Pubitemid 30017249)
5. Frostegard J, Ulfgren AK, Nyberg P, et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999;145(1):33-43. (Pubitemid 29292698)
6. Stein JH, Klein MA, Bellehumeur JL, et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation. 2001;104(3):257-262. (Pubitemid 32666944)
7. Vidrine D. The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDS. 2007;21(9):659-666. (Pubitemid 47525389)
8. Feffer SE, Fox RL, Orsen MM, Harjai KJ, Glatt AE. Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South Med J. 1995;88(11):1126-1130.
9. Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood. 1993;81(7):1801-1807. (Pubitemid 23101593)
10. Toulon P, Lamine M, Ledjev I, et al. Heparin cofactor II deficiency in patients infected with the human immunodeficiency virus. Thromb Haemost. 1993;70(5):730-735. (Pubitemid 23339443)
11. Klein SK, Slim EJ, de Kruif MD, et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med. 2005;63(4):129-136. (Pubitemid 40561527)
12. Trotti R, Rondanelli M, Anesi A, Gabanti E, Brustia R, Minoli L. Increased erythrocyte glutathione peroxidase activity and serum tumor necrosis factor-alpha in HIV-infected patients: relationship to on-going prothrombotic state. J Hematother Stem Cell Res. 2002;11(2):369-375. (Pubitemid 34309530)
13. Blann A, Constans J, Dignat-George F, Seigneur M. The platelet and endothelium in HIV infection. Br J Haematol. 1998;100(3):613-614.
14. Abuaf N, Laperche S, Rajoely B, et al. Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost. 1997;77(5):856-861. (Pubitemid 27239104)
15. George S. Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: report of seven cases. Am J Med. 1999;107(6):624-6.
16. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;346(10):752-763. (Pubitemid 34983997)
17. de Gaetano Donati K, Rabagliati R, Iacoviello L, Cauda R. HIV infection, HAART, and endothelial adhesion molecules: current perspectives. Lancet Infect Dis. 2004;4(4):213-222.
18. Sudano I. Cardiovascular disease in HIV infection. Am Heart J. 2006;151(6):1147-1155. (Pubitemid 44172869)
19. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96(12):4219-4225.
20. Bissuel F, Berruyer M, Causse X, Dechavanne M, Trepo C. Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr. 1992;5(5):484-489.
21. Carr A. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. AIDS. 1997;11(13):1657-1658. (Pubitemid 27460261)
22. Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993-2003.
23. Becker AC, Sliwa K, Stewart S, Libhaber E, Essop AR, EssopMR. Acute coronary syndromes in black South African patients with human immunodeficiency virus infection: the clinical and angiographic features. Circulation. 2008;118(12):e246.
24. Van der Werf F. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Task force of the ESC. Eur Heart J. 2003;24(1):28-66.
25. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2002;23(23):1809-1840.
26. Matsuda J, Gotoh M. Classification system for HIV infection by CDC. Nippon Rinsho 1993; suppl:243-248.
27. Yusuf S, Hawken S, Ounpuu S, et al, for the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study. Lancet. 2004;364(9438):937-952.
28. von Clauss A. Rapid physiological method in determination of fibrinogen [in German]. Acta Haematol. 1957;17(4):237-246.
29. Sliwa K, Wilkinson D, Hansen C, et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet. 2008;371(9616):915-922. (Pubitemid 351375275)
30. Hsue PY, Giri K, Erickson S, et al. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation. 2004;109(3):316-319. (Pubitemid 38133896)
31. Lijfering WM, Ten Kate MK, Sprenger HG, van der Meer J. Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy. J Thromb Haemost. 2006;4(9):1928-1930. (Pubitemid 44226770)
32. Mujawar Z, Rose H, Sviridov D. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLos Biol. 2006;4(11):1970-1983. (Pubitemid 44760013)
33. Bukrinsky M, Sviridov D. Human immunodeficiency virus infection and macrophage cholesterol metabolism. J Leukoc Biol. 2006;80(5):1044-1051. (Pubitemid 44646310)
34. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circulation. 2006;98(11):1352-1364. (Pubitemid 43948059)
35. Boekholdt SM, Kramer MH. Arterial thrombosis and the role of thrombophilia. Semin Thromb Hemost. 2007;33(6):588-596. (Pubitemid 47429311)
36. Tiong IY, Alkotob ML, Ghaffari S. Protein C deficiency manifesting as an acute myocardial infarction and ischaemic stroke. Heart. 2003;89(2):E7.
37. Peterman MA, Roberts WC. Syndrome of protein C deficiency and anterior wall acute myocardial infarction at a young age from a single coronary occlusion with otherwise normal coronary arteries. Am J Cardiol. 2003;92(6):768-770. (Pubitemid 37103045)
38. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurence of deep-vein thrombosis. Lancet. 1995;345(8493):152-155.
39. Zuckerman E, Toubi E, Shiran A, et al. Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study. Am J Med. 1996;101(4):381-386. (Pubitemid 26392855)
40. Loizou S, Singh S, Wypkema E, Asherson RA. Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis. 2003;62(11):1106-1111.
41. Lafon ME, Steffan AM, Royer C, et al. HIV-1 infection induces functional alterations in human liver endothelial cells in primary culture. AIDS. 1994;8(6):747-752. (Pubitemid 24163415)
42. Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol. 2007;50(19):1822-1834. (Pubitemid 350007957)
43. Aboulafia DM, Mitsuyasu RT. Hematologic abnormalities in AIDS. Hematol Oncol Clin North Am. 1991;5(2):195-214.
44. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457.